Medical Subject Headings
MeSH Tree Structures - 2011
C18 - Nutritional and Metabolic Diseases
- Nutritional and Metabolic Diseases [C18]
- Metabolic Diseases [C18.452]
- Acid-Base Imbalance [C18.452.076]
- Brain Diseases, Metabolic [C18.452.132]
- Brain Diseases, Metabolic, Inborn [C18.452.132.100]
- Cerebral Amyloid Angiopathy, Familial [C18.452.132.100.168]
- Galactosemias [C18.452.132.100.320]
- Hartnup Disease [C18.452.132.100.355]
- Hepatolenticular Degeneration [C18.452.132.100.360]
- Hereditary Central Nervous System Demyelinating Diseases [C18.452.132.100.362]
- Homocystinuria [C18.452.132.100.365]
- Hyperglycinemia, Nonketotic [C18.452.132.100.375]
- Hyperlysinemias [C18.452.132.100.380]
- Leigh Disease [C18.452.132.100.412]
- Lesch-Nyhan Syndrome [C18.452.132.100.425]
- Lysosomal Storage Diseases, Nervous System [C18.452.132.100.435]
- Fucosidosis [C18.452.132.100.435.295]
- Glycogen Storage Disease Type II [C18.452.132.100.435.340]
- Mucolipidoses [C18.452.132.100.435.590]
- Sialic Acid Storage Disease [C18.452.132.100.435.810]
- Sphingolipidoses [C18.452.132.100.435.825]
- Fabry Disease [C18.452.132.100.435.825.200]
- Farber Lipogranulomatosis [C18.452.132.100.435.825.250]
- Gangliosidoses [C18.452.132.100.435.825.300]
- Gaucher Disease [C18.452.132.100.435.825.400]
- Leukodystrophy, Globoid Cell [C18.452.132.100.435.825.590]
- Niemann-Pick Diseases [C18.452.132.100.435.825.700]
- Sea-Blue Histiocyte Syndrome [C18.452.132.100.435.825.775]
- Sulfatidosis [C18.452.132.100.435.825.850]
- Maple Syrup Urine Disease [C18.452.132.100.520]
- MELAS Syndrome [C18.452.132.100.535]
- Menkes Kinky Hair Syndrome [C18.452.132.100.540]
- MERRF Syndrome [C18.452.132.100.545]
- Oculocerebrorenal Syndrome [C18.452.132.100.640]
- Peroxisomal Disorders [C18.452.132.100.680]
- Phenylketonurias [C18.452.132.100.687]
- Pyruvate Carboxylase Deficiency Disease [C18.452.132.100.725]
- Pyruvate Dehydrogenase Complex Deficiency Disease [C18.452.132.100.750]
- Tyrosinemias [C18.452.132.100.875]
- Urea Cycle Disorders, Inborn [C18.452.132.100.937]
- Hepatic Encephalopathy [C18.452.132.360]
- Kernicterus [C18.452.132.480]
- Mitochondrial Encephalomyopathies [C18.452.132.540]
- Myelinolysis, Central Pontine [C18.452.132.560]
- Reye Syndrome [C18.452.132.780]
- Wernicke Encephalopathy [C18.452.132.960]
- Brain Diseases, Metabolic, Inborn [C18.452.132.100]
- Calcium Metabolism Disorders [C18.452.174]
- DNA Repair-Deficiency Disorders [C18.452.284]
- Ataxia Telangiectasia [C18.452.284.060]
- Bloom Syndrome [C18.452.284.100]
- Cockayne Syndrome [C18.452.284.250]
- Colorectal Neoplasms, Hereditary Nonpolyposis [C18.452.284.255]
- Fanconi Anemia [C18.452.284.280]
- Li-Fraumeni Syndrome [C18.452.284.520]
- Nijmegen Breakage Syndrome [C18.452.284.600]
- Rothmund-Thomson Syndrome [C18.452.284.760]
- Severe Combined Immunodeficiency [C18.452.284.800]
- Werner Syndrome [C18.452.284.960]
- Xeroderma Pigmentosum [C18.452.284.975]
- Glucose Metabolism Disorders [C18.452.394]
- Diabetes Mellitus [C18.452.394.750]
- Diabetes Mellitus, Experimental [C18.452.394.750.074]
- Diabetes Mellitus, Type 1 [C18.452.394.750.124]
- Diabetes Mellitus, Type 2 [C18.452.394.750.149]
- Diabetes, Gestational [C18.452.394.750.448]
- Diabetic Ketoacidosis [C18.452.394.750.535]
- Donohue Syndrome [C18.452.394.750.654]
- Prediabetic State [C18.452.394.750.774]
- Glycosuria [C18.452.394.937]
- Hyperglycemia [C18.452.394.952]
- Hyperinsulinism [C18.452.394.968]
- Hypoglycemia [C18.452.394.984]
- Diabetes Mellitus [C18.452.394.750]
- Iron Metabolism Disorders [C18.452.565]
- Lipid Metabolism Disorders [C18.452.584]
- Dyslipidemias [C18.452.584.500]
- Hyperlipidemias [C18.452.584.500.500]
- Hypolipoproteinemias [C18.452.584.500.875]
- Smith-Lemli-Opitz Syndrome [C18.452.584.500.937]
- Lipid Metabolism, Inborn Errors [C18.452.584.562]
- Lipodystrophy [C18.452.584.625]
- Lipidoses [C18.452.584.687]
- Cholesterol Ester Storage Disease [C18.452.584.687.201]
- Neuronal Ceroid-Lipofuscinoses [C18.452.584.687.509]
- Sjogren-Larsson Syndrome [C18.452.584.687.723]
- Sphingolipidoses [C18.452.584.687.803]
- Fabry Disease [C18.452.584.687.803.300]
- Farber Lipogranulomatosis [C18.452.584.687.803.325]
- Gangliosidoses [C18.452.584.687.803.350]
- Gaucher Disease [C18.452.584.687.803.441]
- Leukodystrophy, Globoid Cell [C18.452.584.687.803.585]
- Niemann-Pick Diseases [C18.452.584.687.803.730]
- Sea-Blue Histiocyte Syndrome [C18.452.584.687.803.850]
- Sulfatidosis [C18.452.584.687.803.925]
- Lipomatosis [C18.452.584.718]
- Xanthomatosis [C18.452.584.750]
- Dyslipidemias [C18.452.584.500]
- Malabsorption Syndromes [C18.452.603]
- Metabolic Syndrome X [C18.452.625]
- Metabolism, Inborn Errors [C18.452.648]
- Amino Acid Metabolism, Inborn Errors [C18.452.648.100]
- Albinism [C18.452.648.100.102]
- Alkaptonuria [C18.452.648.100.187]
- Hyperglycinemia, Nonketotic [C18.452.648.100.477]
- Hyperhomocysteinemia [C18.452.648.100.480]
- Hyperlysinemias [C18.452.648.100.544]
- Maple Syrup Urine Disease [C18.452.648.100.608]
- Multiple Acyl Coenzyme A Dehydrogenase Deficiency [C18.452.648.100.614]
- Multiple Carboxylase Deficiency [C18.452.648.100.620]
- Phenylketonurias [C18.452.648.100.766]
- Propionic Acidemia [C18.452.648.100.823]
- Tyrosinemias [C18.452.648.100.880]
- Urea Cycle Disorders, Inborn [C18.452.648.100.940]
- Amino Acid Transport Disorders, Inborn [C18.452.648.151]
- Amyloidosis, Familial [C18.452.648.176]
- Brain Diseases, Metabolic, Inborn [C18.452.648.189]
- Cerebral Amyloid Angiopathy, Familial [C18.452.648.189.168]
- Galactosemias [C18.452.648.189.320]
- Hartnup Disease [C18.452.648.189.355]
- Hepatolenticular Degeneration [C18.452.648.189.360]
- Hereditary Central Nervous System Demyelinating Diseases [C18.452.648.189.362]
- Homocystinuria [C18.452.648.189.365]
- Hyperglycinemia, Nonketotic [C18.452.648.189.375]
- Hyperlysinemias [C18.452.648.189.380]
- Leigh Disease [C18.452.648.189.412]
- Lesch-Nyhan Syndrome [C18.452.648.189.425]
- Lysosomal Storage Diseases, Nervous System [C18.452.648.189.435]
- Fucosidosis [C18.452.648.189.435.295]
- Glycogen Storage Disease Type II [C18.452.648.189.435.340]
- Mucolipidoses [C18.452.648.189.435.590]
- Sialic Acid Storage Disease [C18.452.648.189.435.810]
- Sphingolipidoses [C18.452.648.189.435.825]
- Fabry Disease [C18.452.648.189.435.825.200]
- Farber Lipogranulomatosis [C18.452.648.189.435.825.250]
- Gangliosidoses [C18.452.648.189.435.825.300]
- Gaucher Disease [C18.452.648.189.435.825.400]
- Leukodystrophy, Globoid Cell [C18.452.648.189.435.825.590]
- Niemann-Pick Diseases [C18.452.648.189.435.825.700]
- Sea-Blue Histiocyte Syndrome [C18.452.648.189.435.825.775]
- Sulfatidosis [C18.452.648.189.435.825.850]
- Maple Syrup Urine Disease [C18.452.648.189.520]
- MELAS Syndrome [C18.452.648.189.535]
- Menkes Kinky Hair Syndrome [C18.452.648.189.540]
- MERRF Syndrome [C18.452.648.189.545]
- Oculocerebrorenal Syndrome [C18.452.648.189.640]
- Peroxisomal Disorders [C18.452.648.189.680]
- Phenylketonurias [C18.452.648.189.687]
- Pyruvate Carboxylase Deficiency Disease [C18.452.648.189.725]
- Pyruvate Dehydrogenase Complex Deficiency Disease [C18.452.648.189.750]
- Tyrosinemias [C18.452.648.189.875]
- Urea Cycle Disorders, Inborn [C18.452.648.189.937]
- Carbohydrate Metabolism, Inborn Errors [C18.452.648.202]
- Congenital Disorders of Glycosylation [C18.452.648.202.125]
- Fructose Metabolism, Inborn Errors [C18.452.648.202.251]
- Fucosidosis [C18.452.648.202.303]
- Galactosemias [C18.452.648.202.355]
- Glucosephosphate Dehydrogenase Deficiency [C18.452.648.202.402]
- Glycogen Storage Disease [C18.452.648.202.449]
- Glycogen Storage Disease Type I [C18.452.648.202.449.448]
- Glycogen Storage Disease Type II [C18.452.648.202.449.500]
- Glycogen Storage Disease Type IIb [C18.452.648.202.449.510]
- Glycogen Storage Disease Type III [C18.452.648.202.449.520]
- Glycogen Storage Disease Type IV [C18.452.648.202.449.540]
- Glycogen Storage Disease Type V [C18.452.648.202.449.560]
- Glycogen Storage Disease Type VI [C18.452.648.202.449.580]
- Glycogen Storage Disease Type VII [C18.452.648.202.449.600]
- Glycogen Storage Disease Type VIII [C18.452.648.202.449.620]
- Hyperoxaluria, Primary [C18.452.648.202.460]
- Lactose Intolerance [C18.452.648.202.589]
- Mannosidase Deficiency Diseases [C18.452.648.202.607]
- Mucolipidoses [C18.452.648.202.670]
- Mucopolysaccharidoses [C18.452.648.202.715]
- Mucopolysaccharidosis I [C18.452.648.202.715.640]
- Mucopolysaccharidosis II [C18.452.648.202.715.645]
- Mucopolysaccharidosis III [C18.452.648.202.715.650]
- Mucopolysaccharidosis IV [C18.452.648.202.715.655]
- Mucopolysaccharidosis VI [C18.452.648.202.715.670]
- Mucopolysaccharidosis VII [C18.452.648.202.715.675]
- Multiple Carboxylase Deficiency [C18.452.648.202.720]
- Pyruvate Metabolism, Inborn Errors [C18.452.648.202.810]
- Hyperbilirubinemia, Hereditary [C18.452.648.300]
- Lipid Metabolism, Inborn Errors [C18.452.648.398]
- Barth Syndrome [C18.452.648.398.224]
- Hyperlipidemia, Familial Combined [C18.452.648.398.450]
- Hyperlipoproteinemia Type I [C18.452.648.398.465]
- Hyperlipoproteinemia Type II [C18.452.648.398.481]
- Hyperlipoproteinemia Type III [C18.452.648.398.483]
- Hyperlipoproteinemia Type IV [C18.452.648.398.487]
- Hyperlipoproteinemia Type V [C18.452.648.398.493]
- Hypolipoproteinemias [C18.452.648.398.500]
- Lipidoses [C18.452.648.398.641]
- Cholesterol Ester Storage Disease [C18.452.648.398.641.201]
- Neuronal Ceroid-Lipofuscinoses [C18.452.648.398.641.509]
- Sjogren-Larsson Syndrome [C18.452.648.398.641.723]
- Sphingolipidoses [C18.452.648.398.641.803]
- Fabry Disease [C18.452.648.398.641.803.300]
- Farber Lipogranulomatosis [C18.452.648.398.641.803.325]
- Gangliosidoses [C18.452.648.398.641.803.350]
- Gaucher Disease [C18.452.648.398.641.803.441]
- Leukodystrophy, Globoid Cell [C18.452.648.398.641.803.585]
- Niemann-Pick Diseases [C18.452.648.398.641.803.730]
- Sea-Blue Histiocyte Syndrome [C18.452.648.398.641.803.850]
- Sulfatidosis [C18.452.648.398.641.803.925]
- Smith-Lemli-Opitz Syndrome [C18.452.648.398.850]
- Xanthomatosis, Cerebrotendinous [C18.452.648.398.925]
- Lysosomal Storage Diseases [C18.452.648.595]
- Aspartylglucosaminuria [C18.452.648.595.100]
- Cholesterol Ester Storage Disease [C18.452.648.595.201]
- Cystinosis [C18.452.648.595.377]
- Lysosomal Storage Diseases, Nervous System [C18.452.648.595.554]
- Fucosidosis [C18.452.648.595.554.295]
- Glycogen Storage Disease Type II [C18.452.648.595.554.340]
- Mucolipidoses [C18.452.648.595.554.590]
- Sialic Acid Storage Disease [C18.452.648.595.554.810]
- Sphingolipidoses [C18.452.648.595.554.825]
- Fabry Disease [C18.452.648.595.554.825.200]
- Farber Lipogranulomatosis [C18.452.648.595.554.825.250]
- Gangliosidoses [C18.452.648.595.554.825.300]
- Gaucher Disease [C18.452.648.595.554.825.400]
- Leukodystrophy, Globoid Cell [C18.452.648.595.554.825.590]
- Niemann-Pick Diseases [C18.452.648.595.554.825.700]
- Sea-Blue Histiocyte Syndrome [C18.452.648.595.554.825.775]
- Sulfatidosis [C18.452.648.595.554.825.850]
- Mannosidase Deficiency Diseases [C18.452.648.595.577]
- Mucopolysaccharidoses [C18.452.648.595.600]
- Mucopolysaccharidosis I [C18.452.648.595.600.640]
- Mucopolysaccharidosis II [C18.452.648.595.600.645]
- Mucopolysaccharidosis III [C18.452.648.595.600.650]
- Mucopolysaccharidosis IV [C18.452.648.595.600.655]
- Mucopolysaccharidosis VI [C18.452.648.595.600.670]
- Mucopolysaccharidosis VII [C18.452.648.595.600.675]
- Pycnodysostosis [C18.452.648.595.800]
- Metal Metabolism, Inborn Errors [C18.452.648.618]
- Hemochromatosis [C18.452.648.618.337]
- Hepatolenticular Degeneration [C18.452.648.618.403]
- Hypophosphatasia [C18.452.648.618.482]
- Hypophosphatemia, Familial [C18.452.648.618.544]
- Menkes Kinky Hair Syndrome [C18.452.648.618.590]
- Paralyses, Familial Periodic [C18.452.648.618.711]
- Pseudohypoparathyroidism [C18.452.648.618.815]
- Peroxisomal Disorders [C18.452.648.663]
- Acatalasia [C18.452.648.663.025]
- Adrenoleukodystrophy [C18.452.648.663.112]
- Chondrodysplasia Punctata, Rhizomelic [C18.452.648.663.200]
- Mevalonate Kinase Deficiency [C18.452.648.663.480]
- Refsum Disease [C18.452.648.663.760]
- Refsum Disease, Infantile [C18.452.648.663.865]
- Zellweger Syndrome [C18.452.648.663.970]
- Porphyrias [C18.452.648.708]
- Porphyria, Erythropoietic [C18.452.648.708.250]
- Porphyrias, Hepatic [C18.452.648.708.400]
- Coproporphyria, Hereditary [C18.452.648.708.400.074]
- Porphyria, Acute Intermittent [C18.452.648.708.400.150]
- Porphyria Cutanea Tarda [C18.452.648.708.400.250]
- Porphyria, Hepatoerythropoietic [C18.452.648.708.400.437]
- Porphyria, Variegate [C18.452.648.708.400.625]
- Protoporphyria, Erythropoietic [C18.452.648.708.400.812]
- Progeria [C18.452.648.753]
- Purine-Pyrimidine Metabolism, Inborn Errors [C18.452.648.798]
- Renal Tubular Transport, Inborn Errors [C18.452.648.861]
- Acidosis, Renal Tubular [C18.452.648.861.093]
- Dent Disease [C18.452.648.861.271]
- Fanconi Syndrome [C18.452.648.861.450]
- Gitelman Syndrome [C18.452.648.861.491]
- Glycosuria, Renal [C18.452.648.861.532]
- Hypophosphatemia, Familial [C18.452.648.861.647]
- Liddle Syndrome [C18.452.648.861.698]
- Oculocerebrorenal Syndrome [C18.452.648.861.750]
- Pseudohypoaldosteronism [C18.452.648.861.770]
- Renal Aminoacidurias [C18.452.648.861.885]
- Steroid Metabolism, Inborn Errors [C18.452.648.925]
- Amino Acid Metabolism, Inborn Errors [C18.452.648.100]
- Mitochondrial Diseases [C18.452.660]
- Carbamoyl-Phosphate Synthase I Deficiency Disease [C18.452.660.097]
- Cytochrome-c Oxidase Deficiency [C18.452.660.195]
- Friedreich Ataxia [C18.452.660.300]
- Kearns-Sayre Syndrome [C18.452.660.410]
- Leigh Disease [C18.452.660.520]
- Mitochondrial Myopathies [C18.452.660.560]
- Multiple Acyl Coenzyme A Dehydrogenase Deficiency [C18.452.660.612]
- Optic Atrophy, Autosomal Dominant [C18.452.660.665]
- Optic Atrophy, Hereditary, Leber [C18.452.660.670]
- Pyruvate Carboxylase Deficiency Disease [C18.452.660.705]
- Pyruvate Dehydrogenase Complex Deficiency Disease [C18.452.660.710]
- Phosphorus Metabolism Disorders [C18.452.750]
- Porphyrias [C18.452.811]
- Proteostasis Deficiencies [C18.452.845]
- Skin Diseases, Metabolic [C18.452.880]
- Lipodystrophy [C18.452.880.391]
- Necrobiosis Lipoidica [C18.452.880.495]
- Porphyrias [C18.452.880.617]
- Porphyria, Erythropoietic [C18.452.880.617.250]
- Porphyrias, Hepatic [C18.452.880.617.400]
- Coproporphyria, Hereditary [C18.452.880.617.400.074]
- Porphyria, Acute Intermittent [C18.452.880.617.400.150]
- Porphyria Cutanea Tarda [C18.452.880.617.400.250]
- Porphyria, Hepatoerythropoietic [C18.452.880.617.400.437]
- Porphyria, Variegate [C18.452.880.617.400.625]
- Protoporphyria, Erythropoietic [C18.452.880.617.400.812]
- Wasting Syndrome [C18.452.915]
- Water-Electrolyte Imbalance [C18.452.950]
- Nutrition Disorders [C18.654]
- Child Nutrition Disorders [C18.654.180]
- Hypervitaminosis A [C18.654.301]
- Infant Nutrition Disorders [C18.654.422]
- Malnutrition [C18.654.521]
- Deficiency Diseases [C18.654.521.500]
- Avitaminosis [C18.654.521.500.133]
- Ascorbic Acid Deficiency [C18.654.521.500.133.115]
- Vitamin A Deficiency [C18.654.521.500.133.628]
- Vitamin B Deficiency [C18.654.521.500.133.699]
- Choline Deficiency [C18.654.521.500.133.699.160]
- Folic Acid Deficiency [C18.654.521.500.133.699.308]
- Hyperhomocysteinemia [C18.654.521.500.133.699.418]
- Pellagra [C18.654.521.500.133.699.529]
- Riboflavin Deficiency [C18.654.521.500.133.699.713]
- Thiamine Deficiency [C18.654.521.500.133.699.827]
- Vitamin B 6 Deficiency [C18.654.521.500.133.699.901]
- Vitamin B 12 Deficiency [C18.654.521.500.133.699.923]
- Vitamin D Deficiency [C18.654.521.500.133.770]
- Vitamin E Deficiency [C18.654.521.500.133.841]
- Vitamin K Deficiency [C18.654.521.500.133.912]
- Magnesium Deficiency [C18.654.521.500.439]
- Potassium Deficiency [C18.654.521.500.617]
- Protein Deficiency [C18.654.521.500.708]
- Swayback [C18.654.521.500.857]
- Avitaminosis [C18.654.521.500.133]
- Fetal Nutrition Disorders [C18.654.521.625]
- Refeeding Syndrome [C18.654.521.687]
- Starvation [C18.654.521.750]
- Deficiency Diseases [C18.654.521.500]
- Overnutrition [C18.654.726]
- Wasting Syndrome [C18.654.940]
- Metabolic Diseases [C18.452]
Copyright, Privacy, Accessibility, Site Map, Viewers and Players
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, NLM Customer Support
U.S. National Library of Medicine, 8600 Rockville Pike, Bethesda, MD 20894
National Institutes of Health, Health & Human Services
Freedom of Information Act, NLM Customer Support
